Skip to content
10-K

Annual Report

AbCellera Biologics Inc. ABCL

0001703057-26-000012

← back to feed
Filed
Feb 24, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 19, 2026 303.16M sh
Shares Diluted FY 2025 · Dec 31, 2025 298.71M sh
Shares Diluted FY 2025 · Dec 31, 2024 294.33M sh
Shares Diluted FY 2025 · Dec 31, 2023 289.17M sh
Capex FY 2025 · Dec 31, 2025 $42.77M
Capex FY 2025 · Dec 31, 2024 $78.4M
Capex FY 2025 · Dec 31, 2023 $76.95M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$131.3M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$108.56M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$43.88M
Cash And Equivalents FY 2025 · Dec 31, 2025 61.8M
Cash And Equivalents FY 2025 · Dec 31, 2025 $128.51M
Cash And Equivalents FY 2025 · Dec 31, 2024 55.6M
Cash And Equivalents FY 2025 · Dec 31, 2024 $156.33M
Stockholders Equity FY 2025 · Dec 31, 2025 $966.9M
Stockholders Equity FY 2025 · Dec 31, 2024 $1.06B
Stockholders Equity FY 2025 · Dec 31, 2023 $1.15B
Stockholders Equity FY 2025 · Dec 31, 2022 $1.23B
Current Liabilities FY 2025 · Dec 31, 2025 $64.31M
Current Liabilities FY 2025 · Dec 31, 2024 $76.61M
Total Liabilities FY 2025 · Dec 31, 2025 $390.05M
Total Liabilities FY 2025 · Dec 31, 2024 $304.47M
Current Assets FY 2025 · Dec 31, 2025 $728.23M
Current Assets FY 2025 · Dec 31, 2024 $751.37M
Total Assets FY 2025 · Dec 31, 2025 $1.36B
Total Assets FY 2025 · Dec 31, 2024 $1.36B
Eps Diluted FY 2025 · Dec 31, 2025 −$0.49
Eps Diluted FY 2025 · Dec 31, 2024 −$0.55
Eps Diluted FY 2025 · Dec 31, 2023 −$0.51
Eps Basic FY 2025 · Dec 31, 2025 −$0.49
Eps Basic FY 2025 · Dec 31, 2024 −$0.55
Eps Basic FY 2025 · Dec 31, 2023 −$0.51
Rd Expense FY 2025 · Dec 31, 2025 $186.83M
Rd Expense FY 2025 · Dec 31, 2024 $167.26M
Rd Expense FY 2025 · Dec 31, 2023 $175.66M
Net Income FY 2025 · Dec 31, 2025 −$146.41M
Net Income FY 2025 · Dec 31, 2024 −$162.86M
Net Income FY 2025 · Dec 31, 2023 −$146.4M
Operating Income FY 2025 · Dec 31, 2025 −$217.1M
Operating Income FY 2025 · Dec 31, 2024 −$314.77M
Operating Income FY 2025 · Dec 31, 2023 −$237.21M
Revenue FY 2025 · Dec 31, 2025 $75.13M
Revenue FY 2025 · Dec 31, 2024 $28.83M
Revenue FY 2025 · Dec 31, 2023 $38.03M